companydata.dkcompanydata.dk

SYNTERACTHCR DENMARK ApS: Financial statements 2014

CVR: 34055572

Source: annual report 2014, Danish Business Authority

01/01/2014 – 31/12/2014

SYNTERACTHCR DENMARK ApS (CVR 34055572) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 684,953 and a net result of DKK -315,838 compared with DKK -2,992,539 the year before. That is an increase of 61.1% compared with the year before. Equity in the 2014 report amounted to DKK -6,585,903.

Gross Profit
DKK 684,953
Profit/Loss
DKK -315,838
Equity
DKK -6,585,903
Total Assets
DKK 1,871,711

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2014-685 t.-316 t.-6.6 mio.-
2013-425 t.-3 mio.-6.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2014

Martina Kroener joins SYNTERACTHCR DENMARK ApS as directorSep 24, 2014

As of September 24, 2014, Martina Kroener is registered as director of SYNTERACTHCR DENMARK ApS.

Benedikt Van Nieuwenhove steps down as director of SYNTERACTHCR DENMARK ApSSep 23, 2014

As of September 23, 2014, Benedikt Van Nieuwenhove has stepped down as director of SYNTERACTHCR DENMARK ApS.

SYNTERACTHCR DENMARK ApS: The 2013 annual report is outMay 20, 2014

SYNTERACTHCR DENMARK ApS has published its annual report for 2013. Gross profit came to DKK 425,109, and the net result was DKK -2,992,539.

HARRISON CLINICAL RESEARCH SCANDINAVIA ApS changes name to SYNTERACTHCR DENMARK ApSMar 12, 2014

On March 12, 2014, the company changed its name from HARRISON CLINICAL RESEARCH SCANDINAVIA ApS to SYNTERACTHCR DENMARK ApS.

About SYNTERACTHCR DENMARK ApS

SYNTERACTHCR DENMARK ApS was a Danish company of the type Anpartsselskab based in Valby, founded in 2011. The company has been dissolved on 15 May 2024. The company was registered under the industry Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named HARRISON CLINICAL RESEARCH SCANDINAVIA ApS. The company has 0 employees (2014). In 2022, the company reported a gross profit of DKK 3,546 and a net result of DKK -168,380 compared with DKK -266,317 the year before. Equity in the 2022 report amounted to DKK 21,934.

Source: annual report 2022, Danish Business Authority